• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Flt3配体cDNA与CpG寡脱氧核苷酸联合作为鼻腔佐剂可在老年小鼠中引发针对肺炎链球菌的保护性分泌型IgA免疫。

A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice.

作者信息

Fukuyama Yoshiko, King Janice D, Kataoka Kosuke, Kobayashi Ryoki, Gilbert Rebekah S, Hollingshead Susan K, Briles David E, Fujihashi Kohtaro

机构信息

Department of Pediatric Dentistry, Immunobiology Vaccine Center, Institute of Oral Health Research, University of Alabama at Birmingham, AL 35294-0007, USA.

出版信息

J Immunol. 2011 Feb 15;186(4):2454-61. doi: 10.4049/jimmunol.1002837. Epub 2011 Jan 17.

DOI:10.4049/jimmunol.1002837
PMID:21242514
Abstract

Our previous study showed that a combination of a plasmid-expressing Flt3 ligand (pFL) and CpG oligodeoxynucleotides (CpG ODN) as a combined nasal adjuvant elicited mucosal immune responses in aged (2-y-old) mice. In this study, we investigated whether a combination of pFL and CpG ODN as a nasal adjuvant for a pneumococcal surface protein A (PspA) would enhance PspA-specific secretory-IgA Ab responses, which could provide protective mucosal immunity against Streptococcus pneumoniae infection in aged mice. Nasal immunization with PspA plus a combination of pFL and CpG ODN elicited elevated levels of PspA-specific secretory-IgA Ab responses in external secretions and plasma in both young adult and aged mice. Significant levels of PspA-specific CD4(+) T cell proliferative and PspA-induced Th1- and Th2- type cytokine responses were noted in nasopharyngeal-associated lymphoreticular tissue, cervical lymph nodes, and spleen of aged mice, which were equivalent to those in young adult mice. Additionally, increased numbers of mature-type CD8, CD11b-expressing dendritic cells were detected in mucosal inductive and effector lymphoid tissues of aged mice. Importantly, aged mice given PspA plus a combination of pFL and CpG ODN showed protective immunity against nasal S. pneumoniae colonization. These results demonstrate that nasal delivery of a combined DNA adjuvant offers an attractive possibility for protection against S. pneumoniae in the elderly.

摘要

我们之前的研究表明,表达Flt3配体的质粒(pFL)与CpG寡脱氧核苷酸(CpG ODN)联合作为鼻腔佐剂可在老年(2岁)小鼠中引发黏膜免疫反应。在本研究中,我们调查了pFL与CpG ODN联合作为肺炎球菌表面蛋白A(PspA)的鼻腔佐剂是否会增强PspA特异性分泌型IgA抗体反应,这可为老年小鼠提供针对肺炎链球菌感染的保护性黏膜免疫。用PspA加pFL与CpG ODN联合进行鼻腔免疫,在年轻成年和老年小鼠的外分泌液和血浆中均引发了PspA特异性分泌型IgA抗体反应水平的升高。在老年小鼠的鼻咽相关淋巴组织、颈淋巴结和脾脏中,观察到显著水平的PspA特异性CD4(+) T细胞增殖以及PspA诱导的Th1型和Th2型细胞因子反应,这些反应与年轻成年小鼠相当。此外,在老年小鼠的黏膜诱导和效应淋巴组织中检测到表达成熟型CD8、CD11b的树突状细胞数量增加。重要的是,给予PspA加pFL与CpG ODN联合的老年小鼠对鼻腔肺炎链球菌定植表现出保护性免疫。这些结果表明,鼻腔递送联合DNA佐剂为老年人预防肺炎链球菌感染提供了一种有吸引力的可能性。

相似文献

1
A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice.Flt3配体cDNA与CpG寡脱氧核苷酸联合作为鼻腔佐剂可在老年小鼠中引发针对肺炎链球菌的保护性分泌型IgA免疫。
J Immunol. 2011 Feb 15;186(4):2454-61. doi: 10.4049/jimmunol.1002837. Epub 2011 Jan 17.
2
Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae.分泌型免疫球蛋白 A 抗体在抵抗肺炎链球菌感染中发挥重要作用。
J Immunol. 2010 Aug 1;185(3):1755-62. doi: 10.4049/jimmunol.1000831. Epub 2010 Jun 28.
3
The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia.鼻腔树突状细胞靶向 Flt3 配体作为一种安全的佐剂,可有效预防致死性肺炎球菌肺炎。
Infect Immun. 2011 Jul;79(7):2819-28. doi: 10.1128/IAI.01360-10. Epub 2011 May 2.
4
A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.一种针对肺炎球菌表面蛋白A的黏膜免疫无毒佐剂。
J Immunol. 1998 Oct 15;161(8):4115-21.
5
Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.用于对肺炎链球菌产生保护性黏膜免疫的基于DNA的树突状细胞靶向鼻用佐剂。
Microbiol Immunol. 2017 Jun;61(6):195-205. doi: 10.1111/1348-0421.12487.
6
Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of .呼吸道 FimA 特异性分泌型 IgA 抗体受树突状细胞靶向鼻腔双 DNA 佐剂上调,对清除 至关重要。
Front Immunol. 2021 Feb 25;12:634923. doi: 10.3389/fimmu.2021.634923. eCollection 2021.
7
Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.鼻腔 Flt3 配体 cDNA 疫苗接种对磷酸胆碱的黏膜免疫特征。
Vaccine. 2011 Aug 5;29(34):5747-57. doi: 10.1016/j.vaccine.2011.05.097. Epub 2011 Jun 15.
8
A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.Flt3配体cDNA与CpG ODN作为鼻腔佐剂的组合可引发鼻相关淋巴组织树突状细胞,以实现持久的黏膜免疫。
Vaccine. 2008 Sep 2;26(37):4849-59. doi: 10.1016/j.vaccine.2008.06.091. Epub 2008 Jul 14.
9
The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.与霍乱毒素无毒B亚基相连的CpG寡脱氧核苷酸对小鼠抗幽门螺杆菌免疫诱导的佐剂作用。
Scand J Immunol. 2008 May;67(5):431-40. doi: 10.1111/j.1365-3083.2008.02085.x. Epub 2008 Feb 21.
10
Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.鼻腔内免疫重组 PspA 与鞭毛蛋白融合增强了对肺炎链球菌感染的小鼠交叉保护免疫。
Vaccine. 2011 Aug 5;29(34):5731-9. doi: 10.1016/j.vaccine.2011.05.095. Epub 2011 Jun 13.

引用本文的文献

1
Complex Thrombo-Inflammatory Responses versus Outcomes of Non-COVID-19 Community-Acquired Pneumonia and COVID-19.复杂血栓炎症反应与非新冠病毒感染社区获得性肺炎及新冠病毒感染肺炎的结局对比
J Innate Immun. 2024;16(1):529-552. doi: 10.1159/000542420. Epub 2024 Dec 3.
2
Human salivary protein-derived peptides specific-salivary SIgA antibodies enhanced by nasal double DNA adjuvant in mice play an essential role in preventing Porphyromonas gingivalis colonization: an in-vitro study.经鼻腔双重 DNA 佐剂增强的人唾液蛋白衍生肽特异性唾液 SIgA 抗体在预防牙龈卟啉单胞菌定植中的作用:一项体外研究。
BMC Oral Health. 2023 Feb 24;23(1):123. doi: 10.1186/s12903-023-02821-6.
3
Mucosal vaccines: wisdom from now and then.
黏膜疫苗:今昔智慧。
Int Immunol. 2021 Nov 25;33(12):767-774. doi: 10.1093/intimm/dxab056.
4
Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Vaccine.细胞基础为 Fms-样酪氨酸激酶 3 配体 (FL) 佐剂 VCG 基疫苗增强的效力。
Front Immunol. 2021 Jun 24;12:698737. doi: 10.3389/fimmu.2021.698737. eCollection 2021.
5
Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of .呼吸道 FimA 特异性分泌型 IgA 抗体受树突状细胞靶向鼻腔双 DNA 佐剂上调,对清除 至关重要。
Front Immunol. 2021 Feb 25;12:634923. doi: 10.3389/fimmu.2021.634923. eCollection 2021.
6
The Interplay between Immunosenescence and Microbiota in the Efficacy of Vaccines.免疫衰老与微生物群在疫苗效力中的相互作用
Vaccines (Basel). 2020 Nov 2;8(4):636. doi: 10.3390/vaccines8040636.
7
Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection.一种针对人FcγRI的三价无佐剂亚单位粘膜疫苗抗肺部肺炎球菌感染的临床前疗效
Vaccines (Basel). 2020 Apr 23;8(2):193. doi: 10.3390/vaccines8020193.
8
Immunosenescence and human vaccine immune responses.免疫衰老与人类疫苗免疫反应。
Immun Ageing. 2019 Sep 13;16:25. doi: 10.1186/s12979-019-0164-9. eCollection 2019.
9
Nasal double DNA adjuvant induces salivary FimA-specific secretory IgA antibodies in young and aging mice and blocks Porphyromonas gingivalis binding to a salivary protein.鼻腔内双重 DNA 佐剂诱导年轻和老年小鼠产生唾液 FimA 特异性分泌型 IgA 抗体,并阻断牙龈卟啉单胞菌与唾液蛋白的结合。
BMC Oral Health. 2019 Aug 19;19(1):188. doi: 10.1186/s12903-019-0886-2.
10
Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses.疫苗接种途径影响 Fms 样酪氨酸激酶 3 配体 (Flt3L) 对衣原体特异性保护性免疫应答的影响。
Front Immunol. 2019 Jul 4;10:1577. doi: 10.3389/fimmu.2019.01577. eCollection 2019.